-
2
-
-
0012384465
-
Chronic myeloproliferative diseases: Introduction
-
E.S. Jaffe, N.L. Harris, H. Stein, & J.W. Vardiman. Lyon: IARC Press
-
Vardiman J.W., Brunning R.D., Harris N.L. Chronic myeloproliferative diseases. introduction Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. 2001;17-19 IARC Press, Lyon
-
(2001)
World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues
, pp. 17-19
-
-
Vardiman, J.W.1
Brunning, R.D.2
Harris, N.L.3
-
3
-
-
0002459323
-
Myelodysplastic syndromes: Introduction
-
E.S. Jaffe, N.L. Harris, H. Stein, & J.W. Vardiman. Lyon: IARC Press
-
Brunning R.D., Bennett J.M., Flandrin G., et al. Myelodysplastic syndromes. introduction Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. 2001;63-67 IARC Press, Lyon
-
(2001)
World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues
, pp. 63-67
-
-
Brunning, R.D.1
Bennett, J.M.2
Flandrin, G.3
-
5
-
-
0019952276
-
Proposals for the classification of the myelodysplastic syndromes
-
Bennett J.M., Catovsky D., Daniel M.T., et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 51:1982;189-199
-
(1982)
Br J Haematol
, vol.51
, pp. 189-199
-
-
Bennett, J.M.1
Catovsky, D.2
Daniel, M.T.3
-
6
-
-
0028069002
-
The chronic myeloid leukaemias: Guidelines for distinguishing granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals from the French-American-British Cooperative Leukaemia group
-
Bennett J.M., Catovsky D., Daniel M.T., et al. The chronic myeloid leukaemias. guidelines for distinguishing granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals from the French-American-British Cooperative Leukaemia group Br J Haematol. 87:1994;746-754
-
(1994)
Br J Haematol
, vol.87
, pp. 746-754
-
-
Bennett, J.M.1
Catovsky, D.2
Daniel, M.T.3
-
7
-
-
0032857774
-
The relationship between the myeloproliferative syndromes and the myeloproliferative disorders
-
Bain B.J. The relationship between the myeloproliferative syndromes and the myeloproliferative disorders. Leukaemia Lymphoma. 34:1999;443-449
-
(1999)
Leukaemia Lymphoma
, vol.34
, pp. 443-449
-
-
Bain, B.J.1
-
8
-
-
0032823415
-
Thrombocytosis and sideroblastic erythropoiesis: A mixed myeloproliferative myelodysplastic syndrome
-
Gupta R., Abdalla S.H., Bain B.J. Thrombocytosis and sideroblastic erythropoiesis. a mixed myeloproliferative myelodysplastic syndrome Leukaemia Lymphoma. 34:1999;615-619
-
(1999)
Leukaemia Lymphoma
, vol.34
, pp. 615-619
-
-
Gupta, R.1
Abdalla, S.H.2
Bain, B.J.3
-
9
-
-
0344987881
-
A tyrosine kinase created by the fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
-
Cools J., DeAngelo D.J., Gotlib J., et al. A tyrosine kinase created by the fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 348:2003;1201-1214
-
(2003)
N Engl J Med
, vol.348
, pp. 1201-1214
-
-
Cools, J.1
Deangelo, D.J.2
Gotlib, J.3
-
10
-
-
2942545086
-
The idiopathic hypereosinophilic syndrome and eosinophilic leukaemias
-
Bain B.J. The idiopathic hypereosinophilic syndrome and eosinophilic leukaemias. Haematologica. 89:2004;134-138
-
(2004)
Haematologica
, vol.89
, pp. 134-138
-
-
Bain, B.J.1
-
11
-
-
0038487039
-
Cytogenetic and molecular genetic aspects of eosinophilic leukaemia
-
Bain B.J. Cytogenetic and molecular genetic aspects of eosinophilic leukaemia. Br J Haematol. 122:2003;173-179
-
(2003)
Br J Haematol
, vol.122
, pp. 173-179
-
-
Bain, B.J.1
-
12
-
-
0942276859
-
Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment with the myeloproliferative variant of hypereosinophilic syndrome
-
in press.
-
Klion AD, Robyn J, Akin C, et al. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment with the myeloproliferative variant of hypereosinophilic syndrome. Blood, 2004, in press.
-
(2004)
Blood
-
-
Klion, A.D.1
Robyn, J.2
Akin, C.3
-
13
-
-
10744228486
-
CHIC2 deletion, a surrogate marker for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy
-
Pardanani A., Ketterling R.P., Brockman S.R., et al. CHIC2 deletion, a surrogate marker for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood. 102:2003;3093-3098
-
(2003)
Blood
, vol.102
, pp. 3093-3098
-
-
Pardanani, A.1
Ketterling, R.P.2
Brockman, S.R.3
-
14
-
-
0017162163
-
Proposals for the classification of the acute leukaemias (FAB cooperative group)
-
Bennett J.M., Catovsky D., Daniel M.T., et al. Proposals for the classification of the acute leukaemias (FAB cooperative group). Br J Haematol. 33:1976;451-458
-
(1976)
Br J Haematol
, vol.33
, pp. 451-458
-
-
Bennett, J.M.1
Catovsky, D.2
Daniel, M.T.3
-
15
-
-
0033757263
-
Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: A retrospective analysis of 1600 patients
-
Germing U., Gatterman N., Strupp C., et al. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes. a retrospective analysis of 1600 patients Leuk Res. 24:2001;983-992
-
(2001)
Leuk Res
, vol.24
, pp. 983-992
-
-
Germing, U.1
Gatterman, N.2
Strupp, C.3
-
16
-
-
0036202064
-
The 8p11 myeloproliferative syndrome: A distinct clinical entity caused by constitutive activation of FGFR1
-
Macdonald D., Reiter A., Cross N.C.P. The 8p11 myeloproliferative syndrome. a distinct clinical entity caused by constitutive activation of FGFR1 Acta Haematol. 107:2002;101-107
-
(2002)
Acta Haematol
, vol.107
, pp. 101-107
-
-
MacDonald, D.1
Reiter, A.2
Cross, N.C.P.3
-
17
-
-
0036202529
-
Myeloproliferative disorders with translocations of chromosome 5q31-35: Role of the platelet-derived growth factor receptor beta
-
Steer E.J., Cross N.C.P. Myeloproliferative disorders with translocations of chromosome 5q31-35. role of the platelet-derived growth factor receptor beta Acta Haematol. 107:2002;113-122
-
(2002)
Acta Haematol
, vol.107
, pp. 113-122
-
-
Steer, E.J.1
Cross, N.C.P.2
-
18
-
-
0037103624
-
Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta
-
Apperley J., Gardembas M., Melo J., et al. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. N Engl J Med. 347:2002;481-487
-
(2002)
N Engl J Med
, vol.347
, pp. 481-487
-
-
Apperley, J.1
Gardembas, M.2
Melo, J.3
|